Page last updated: 2024-10-30

losartan and Cardiovascular Pregnancy Complications

losartan has been researched along with Cardiovascular Pregnancy Complications in 9 studies

Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position

Research Excerpts

ExcerptRelevanceReference
" We report a chronic hypertensive pregnant woman treated with losartan before and throughout pregnancy."3.74[Transient renal failure in a newborn due angiotensin receptor II antagonist use during pregnancy: report of a case]. ( Catalán M, J; Hasbún H, J; Parra C, M; Salinas Q, S; San Martín O, A; Valdés R, E, 2008)
" The mother suffered from essential hypertension and was treated with Cozaar (losartan 50 mg)."3.73Foetal kidney maldevelopment in maternal use of angiotensin II type I receptor antagonists. ( Daïkha-Dahmane, F; Jugie, M; Lenclen, R; Levy-Beff, E, 2006)
" We report a premature infant born to a 41-year-old mother with a long history of infertility who had received losartan therapy for hypertension throughout an undetected pregnancy."3.73Gestational therapy with an angiotensin II receptor antagonist and transient renal failure in a premature infant. ( Bass, JK; Faix, RG, 2006)
"We report a case of maternal exposure to the antihypertensive drug losartan during weeks 20-31 of pregnancy."3.71Losartan and fetal toxic effects. ( Hagiwara, A; Ijiri, R; Saji, H; Yamanaka, M, 2001)
"Losartan is a specific angiotensin II receptor antagonist."1.32Losartan induced fetal toxicity. ( Aggarwal, R; Malhotra, N; Nayar, B; Singhal, A, 2003)

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's8 (88.89)29.6817
2010's1 (11.11)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hasbún H, J1
Valdés R, E1
San Martín O, A1
Catalán M, J1
Salinas Q, S1
Parra C, M1
Gersak, K1
Cvijic, M1
Cerar, LK1
Saito, T1
Musha, Y1
Miyakawa, M1
Itoh, S1
Ohtsuji, M1
Hanson, MA1
Takeda, S1
Nayar, B1
Singhal, A1
Aggarwal, R1
Malhotra, N1
Daïkha-Dahmane, F2
Levy-Beff, E1
Jugie, M1
Lenclen, R1
Bass, JK1
Faix, RG1
Saji, H1
Yamanaka, M1
Hagiwara, A1
Ijiri, R1
Lambot, MA1
Vermeylen, D1
Noël, JC1
Martinovic, J1
Benachi, A1
Laurent, N1
Gubler, MC1

Other Studies

9 other studies available for losartan and Cardiovascular Pregnancy Complications

ArticleYear
[Transient renal failure in a newborn due angiotensin receptor II antagonist use during pregnancy: report of a case].
    Revista medica de Chile, 2008, Volume: 136, Issue:5

    Topics: Acute Kidney Injury; Adult; Angiotensin II Type 1 Receptor Blockers; Creatinine; Female; Gestational

2008
Angiotensin II receptor blockers in pregnancy: a report of five cases.
    Reproductive toxicology (Elmsford, N.Y.), 2009, Volume: 28, Issue:1

    Topics: Abnormalities, Drug-Induced; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Biphe

2009
Angiotensin II receptor antagonist reduces subsequent uterine arterial dysfunction in pregnant offspring of protein-restricted rat dams.
    The journal of obstetrics and gynaecology research, 2012, Volume: 38, Issue:3

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II Type 1 Receptor B

2012
Losartan induced fetal toxicity.
    Indian journal of pediatrics, 2003, Volume: 70, Issue:11

    Topics: Abnormalities, Drug-Induced; Antihypertensive Agents; Female; Fetal Death; Heart Defects, Congenital

2003
Foetal kidney maldevelopment in maternal use of angiotensin II type I receptor antagonists.
    Pediatric nephrology (Berlin, Germany), 2006, Volume: 21, Issue:5

    Topics: Abnormalities, Drug-Induced; Adult; Angiotensin II Type 1 Receptor Blockers; Diseases in Twins; Fema

2006
Gestational therapy with an angiotensin II receptor antagonist and transient renal failure in a premature infant.
    American journal of perinatology, 2006, Volume: 23, Issue:5

    Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Female; Humans; Hypertension; Inf

2006
Losartan and fetal toxic effects.
    Lancet (London, England), 2001, Feb-03, Volume: 357, Issue:9253

    Topics: Adult; Antihypertensive Agents; Contraindications; Female; Fetal Death; Humans; Losartan; Oligohydra

2001
Angiotensin-II-receptor inhibitors in pregnancy.
    Lancet (London, England), 2001, May-19, Volume: 357, Issue:9268

    Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Adult; Antihypertensive Agents; Cesarean Secti

2001
Fetal toxic effects and angiotensin-II-receptor antagonists.
    Lancet (London, England), 2001, Jul-21, Volume: 358, Issue:9277

    Topics: Abnormalities, Drug-Induced; Adult; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensi

2001